(firstQuint)Phase 2 Trial of PED-1 and PED-2 in Male Patients With Premature Ejaculation.

 This study is to evaluate whether PED-1 and PED2 are tolerable and effective in the treatment of premature ejaculation.

 The patients will be randomized and allocated to three treatment groups into placebo, PED-1, and PED-2.

 The creteria for IELT for enrollment will be > or =2 min in the at least 75% of the sexual intercourse.

 To diagnosis premature ejaculation, the PEDT will be used.

 The patients ungone drug free baseline line period will take test drugs for 4 weeks.

.

 Phase 2 Trial of PED-1 and PED-2 in Male Patients With Premature Ejaculation@highlight

The purpose of this study is to evaluate whether PED-1 (15mg) and PED-2 (30mg) are tolerable and effective in the treatment of premature ejaculation.

